phase readout
saveNCT04619004: HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Daiichi Sankyo. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
view source ↗
comments(0)
5-min edit window · permanent after that